Improvement of a potential anthrax therapeutic by computational protein design

Sean J. Wu, Christopher B. Eiben, John H. Carra, Ivan Huang, David Zong, Peixian Liu, Cindy T. Wu, Jeff Nivala, Josef Dunbar, Tomas Huber, Jeffrey Senft, Rowena Schokman, Matthew D. Smith, Jeremy Mills, Arthur M. Friedlander, David Baker, Justin B. Siegel

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Past anthrax attacks in the United States have highlighted the need for improved measures against bioweapons. The virulence of anthrax stems from the shielding properties of the Bacillus anthracis poly-γ-D-glutamic acid capsule. In the presence of excess CapD, a B. anthracis γ-glutamyl transpeptidase, the protective capsule is degraded, and the immune system can successfully combat infection. Although CapD shows promise as a next generation protein therapeutic against anthrax, improvements in production, stability, and therapeutic formulation are needed. In this study, we addressed several of these problems through computational protein engineering techniques. We show that circular permutation of CapD improved production properties and dramatically increased kinetic thermostability. At 45 °C, CapD was completely inactive after 5 min, but circularly permuted CapD remained almost entirely active after 30 min. In addition, we identify an amino acid substitution that dramatically decreased transpeptidation activity but not hydrolysis. Subsequently, we show that this mutant had a diminished capsule degradation activity, suggesting that CapD catalyzes capsule degradation through a transpeptidation reaction with endogenous amino acids and peptides in serum rather than hydrolysis.

Original languageEnglish (US)
Pages (from-to)32586-32592
Number of pages7
JournalJournal of Biological Chemistry
Volume286
Issue number37
DOIs
StatePublished - Sep 16 2011
Externally publishedYes

Fingerprint

Anthrax
Capsules
Bacillus anthracis
Hydrolysis
Proteins
Protein Engineering
Amino Acids
Degradation
gamma-Glutamyltransferase
Immune system
Bacilli
Amino Acid Substitution
Therapeutics
Shielding
Virulence
Glutamic Acid
Immune System
Substitution reactions
Thermodynamic properties
Peptides

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Wu, S. J., Eiben, C. B., Carra, J. H., Huang, I., Zong, D., Liu, P., ... Siegel, J. B. (2011). Improvement of a potential anthrax therapeutic by computational protein design. Journal of Biological Chemistry, 286(37), 32586-32592. https://doi.org/10.1074/jbc.M111.251041

Improvement of a potential anthrax therapeutic by computational protein design. / Wu, Sean J.; Eiben, Christopher B.; Carra, John H.; Huang, Ivan; Zong, David; Liu, Peixian; Wu, Cindy T.; Nivala, Jeff; Dunbar, Josef; Huber, Tomas; Senft, Jeffrey; Schokman, Rowena; Smith, Matthew D.; Mills, Jeremy; Friedlander, Arthur M.; Baker, David; Siegel, Justin B.

In: Journal of Biological Chemistry, Vol. 286, No. 37, 16.09.2011, p. 32586-32592.

Research output: Contribution to journalArticle

Wu, SJ, Eiben, CB, Carra, JH, Huang, I, Zong, D, Liu, P, Wu, CT, Nivala, J, Dunbar, J, Huber, T, Senft, J, Schokman, R, Smith, MD, Mills, J, Friedlander, AM, Baker, D & Siegel, JB 2011, 'Improvement of a potential anthrax therapeutic by computational protein design', Journal of Biological Chemistry, vol. 286, no. 37, pp. 32586-32592. https://doi.org/10.1074/jbc.M111.251041
Wu, Sean J. ; Eiben, Christopher B. ; Carra, John H. ; Huang, Ivan ; Zong, David ; Liu, Peixian ; Wu, Cindy T. ; Nivala, Jeff ; Dunbar, Josef ; Huber, Tomas ; Senft, Jeffrey ; Schokman, Rowena ; Smith, Matthew D. ; Mills, Jeremy ; Friedlander, Arthur M. ; Baker, David ; Siegel, Justin B. / Improvement of a potential anthrax therapeutic by computational protein design. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 37. pp. 32586-32592.
@article{d40d1be5a3d74e318e074d4da002c907,
title = "Improvement of a potential anthrax therapeutic by computational protein design",
abstract = "Past anthrax attacks in the United States have highlighted the need for improved measures against bioweapons. The virulence of anthrax stems from the shielding properties of the Bacillus anthracis poly-γ-D-glutamic acid capsule. In the presence of excess CapD, a B. anthracis γ-glutamyl transpeptidase, the protective capsule is degraded, and the immune system can successfully combat infection. Although CapD shows promise as a next generation protein therapeutic against anthrax, improvements in production, stability, and therapeutic formulation are needed. In this study, we addressed several of these problems through computational protein engineering techniques. We show that circular permutation of CapD improved production properties and dramatically increased kinetic thermostability. At 45 °C, CapD was completely inactive after 5 min, but circularly permuted CapD remained almost entirely active after 30 min. In addition, we identify an amino acid substitution that dramatically decreased transpeptidation activity but not hydrolysis. Subsequently, we show that this mutant had a diminished capsule degradation activity, suggesting that CapD catalyzes capsule degradation through a transpeptidation reaction with endogenous amino acids and peptides in serum rather than hydrolysis.",
author = "Wu, {Sean J.} and Eiben, {Christopher B.} and Carra, {John H.} and Ivan Huang and David Zong and Peixian Liu and Wu, {Cindy T.} and Jeff Nivala and Josef Dunbar and Tomas Huber and Jeffrey Senft and Rowena Schokman and Smith, {Matthew D.} and Jeremy Mills and Friedlander, {Arthur M.} and David Baker and Siegel, {Justin B.}",
year = "2011",
month = "9",
day = "16",
doi = "10.1074/jbc.M111.251041",
language = "English (US)",
volume = "286",
pages = "32586--32592",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "37",

}

TY - JOUR

T1 - Improvement of a potential anthrax therapeutic by computational protein design

AU - Wu, Sean J.

AU - Eiben, Christopher B.

AU - Carra, John H.

AU - Huang, Ivan

AU - Zong, David

AU - Liu, Peixian

AU - Wu, Cindy T.

AU - Nivala, Jeff

AU - Dunbar, Josef

AU - Huber, Tomas

AU - Senft, Jeffrey

AU - Schokman, Rowena

AU - Smith, Matthew D.

AU - Mills, Jeremy

AU - Friedlander, Arthur M.

AU - Baker, David

AU - Siegel, Justin B.

PY - 2011/9/16

Y1 - 2011/9/16

N2 - Past anthrax attacks in the United States have highlighted the need for improved measures against bioweapons. The virulence of anthrax stems from the shielding properties of the Bacillus anthracis poly-γ-D-glutamic acid capsule. In the presence of excess CapD, a B. anthracis γ-glutamyl transpeptidase, the protective capsule is degraded, and the immune system can successfully combat infection. Although CapD shows promise as a next generation protein therapeutic against anthrax, improvements in production, stability, and therapeutic formulation are needed. In this study, we addressed several of these problems through computational protein engineering techniques. We show that circular permutation of CapD improved production properties and dramatically increased kinetic thermostability. At 45 °C, CapD was completely inactive after 5 min, but circularly permuted CapD remained almost entirely active after 30 min. In addition, we identify an amino acid substitution that dramatically decreased transpeptidation activity but not hydrolysis. Subsequently, we show that this mutant had a diminished capsule degradation activity, suggesting that CapD catalyzes capsule degradation through a transpeptidation reaction with endogenous amino acids and peptides in serum rather than hydrolysis.

AB - Past anthrax attacks in the United States have highlighted the need for improved measures against bioweapons. The virulence of anthrax stems from the shielding properties of the Bacillus anthracis poly-γ-D-glutamic acid capsule. In the presence of excess CapD, a B. anthracis γ-glutamyl transpeptidase, the protective capsule is degraded, and the immune system can successfully combat infection. Although CapD shows promise as a next generation protein therapeutic against anthrax, improvements in production, stability, and therapeutic formulation are needed. In this study, we addressed several of these problems through computational protein engineering techniques. We show that circular permutation of CapD improved production properties and dramatically increased kinetic thermostability. At 45 °C, CapD was completely inactive after 5 min, but circularly permuted CapD remained almost entirely active after 30 min. In addition, we identify an amino acid substitution that dramatically decreased transpeptidation activity but not hydrolysis. Subsequently, we show that this mutant had a diminished capsule degradation activity, suggesting that CapD catalyzes capsule degradation through a transpeptidation reaction with endogenous amino acids and peptides in serum rather than hydrolysis.

UR - http://www.scopus.com/inward/record.url?scp=80052723466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052723466&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.251041

DO - 10.1074/jbc.M111.251041

M3 - Article

VL - 286

SP - 32586

EP - 32592

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 37

ER -